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Streptococcus pyogenes is the leading cause of uncomplicated bacterial pharyngitis and tonsillitis 
commonly referred to as strep throat. Erythromycin is administered for patients allergy to penicillin. In 
this study, 125 throat swab samples were collected from children between 2-12 years old with tonsillo-
pharyngitis attended to at the AL-Imammain AL-Kadhimain Medical City-Baghdad-Iraq and Pediatric 
Caring Hospital-Baghdad-Iraq from February 2014 to February 2015. Only 72 throat swab samples 
showed bacterial growth. The isolates were identified using Vitek 2 Compact system for Gram-Positive. 
Antibiotics susceptibility was examined using the BioMérieux Vitek2 compact system AST card. For 
direct molecular identification of S. pyogenes, 16S rRNA and 16S-23S rRNA gene amplification were 
used. Molecular screening for erythromycin resistance genes erm(A), erm(B) and mef(A) were done 
using PCR. The results of identification using Vitek2 GP show that 21 (29.2%) samples were S. 
pyogenes-positive while 51(70.8%) of samples were due to other causes of tonsillo-pharyngitis. The 
results of molecular identification of S. pyogenes strains using 16S rRNA and 16S-23S rRNA 
amplification showed that only four strains were positive for 16S-23S rRNA, while two strains out of 
four were also positive for 16S rRNA. According to the results of antibiotic sensitivity, there were seven 
strains resistant to erythromycin. The results of molecular screening for erythromycin resistant genes 
showed that all these resistant strains did not contain the resistant genes erm(A), erm(B) or mef (A). We 
conclude that, maybe there was a specific sequence variations in genes used for identification of S. 
pyogenes. Also, resistance to erythromycin could be attributed to causes other than the studied 
mutations, such as structural modification of erythromycin by phosphorylation, glycosylation or 
lactone ring cleavage by erythromycin esterase. 
 





Streptococcus pyogenes is the leading cause of uncom-
plicated bacterial pharyngitis and tonsillitis commonly 
referred to as strep throat. It causes up to 15 to 30% of 
cases of acute pharyngitis that occurs in children in the 
age between 5 to 15 years. Other respiratory infections 
include sinusitis, otitis, and pneumonia. Also, it causes 
skin infections and post-streptococcal sequel, rheumatic 
fever, glomerulonephritis that may follow streptococcal 
diseases, and occur in 1 to 3% of untreated infections 
(Cunningham, 2000; Carapetis et al., 2005; Tart et al., 
2007). Accurate diagnosis is essential for appropriate 








antibiotics in acute tonsillitis while macrolides such as 
erythromycin is reserved for patients allergic to penicillin. 
Ketolides such as telithromycin have the activity against 
S. pyogenes which is resistance to erythromycin (Ben 
Zakour et al., 2012; Shulman et al., 2012). The mechanisms 
of action of erythromycin involve the inhibition of bacterial 
protein synthesis by binding reversibly to the subunit 50S 
of the bacterial ribosome, thereby inhibiting translocation 
of peptidyl-tRNA. The action is bacteriostatic, but can 
also be bactericidal in high concentrations (Giguere, 
2013). Resistance to erythromycin in S. pyogenes can be 
caused by the following main mechanisms: 1) modifi-
cation
 
of the 23SrRNA by rRNA adenine-N6-methyl-
transferase encoded by horizontally acquired erm A and 
erm B (Jasir et al., 2000; Giovanetti et al., 2003; Albrich 
et al., 2004; Farrell et al., 2006; Brenciani et al., 2007); 2) 
active drug efflux via a trans-membrane pump encoded 
by horizontally acquired mef. This mechanism is 
mediated by a membrane-associated protein that pumps 
the antibiotic out of the cell, keeping intracellular concen-
trations low and preventing the binding of antibiotics to 
the ribosome (Nord et al., 2004; Del Grosso et al., 2011; 
Giovanetti et al., 2012; Giovanetti et al., 2003) mutations 
comprising a change in domain V of 23S rRNA as a 
result of a mutation in all the six copies of rRNA gene 
(Bingen et al., 2002). Additional mechanisms of 
erythromycin resistance include structural modification of 
erythromycin by phosphorylation (Davies and Davies, 
2010), glycosylation (Hawkey and Jones, 2009), and 
lactone ring cleavage by erythromycin esterase (Levi and 
Marshal, 2004). 
The 16S rRNA and 23S rRNA are targets for 
identification of microorganisms at the species, genus or 
family level. These genes contain both conserved regions 
and areas of variability sufficient for specific identification 
of bacteria. The ribosomal intergenic spacer region (ISR), 
a stretch of DNA that lies between the 16S rRNA and the 
23S rRNA subunit genes, proved to be much more 
variable than the adjacent 16S and 23S ribosomal genes 
and this region can be used as method of differentiation 
of many species within genus and as method of 
identification of certain bacteria (Hassan et al., 2003). In 
this study, molecular identification of S. pyogenes using 
16SrRNA and 23SrRNA and screening for erythromycin 
resistance genes was performed. 
 
 
MATERIALS AND METHODS  
 
Samples collection  
 
One hundred and twenty five throat swab samples were collected 
from children between 2 to 12 years old with tonsillo-pharyngitis 
infections  attended  to by the AL-Imammain AL-Kadhimain Medical 




city-Baghdad-Iraq and Pediatric Caring Hospital-Baghdad-Iraq from 
February 2014 to February 2015. Throat swab samples were taken 
according to clinical evaluation recommendation of physicians 
(Vandepitte et al., 2003). Information from patient parent was taken 
including age, sex, duration of infection, previous treatment and 
stage of throat infection (acute or chronic). The study protocol was 
approved by The Ethical Committee of College of Medicine-Al 
Nahrain University.  
 
 
Identification of S. pyogenes  
 
Throat swab sample was cultured on blood agar plate that was 
incubated aerobically with 5 to 10 % CO2 at 37°C for 18 to 24 h in a 
candle jar (Vandepitte et al., 2003). The blood agar plates were 
examined for morphology and cultural characteristic that include 
appearance of colonies and beta-hemolytic zone around colonies 
on blood agar plate. For purification, growing beta-hemolytic 
streptococci was inoculated on sodium azide media, which is 
consider as a selective agar used for the selective isolation of S. 
pyogenes. Also, catalase test, microscopical examination of Gram 
stain and Bacitracin sensitivity test were done (Vandepitte et al., 
2003). The isolates were identified with Vitek 2 Compact system for 
Gram-Positive Identification, card 2GP (bioMérieux-France). 
 
 
Antibiotics susceptibility assay  
 
Minimal inhibitory concentration (MIC) and antibiotics susceptibility 
were examined using the BioMérieux Vitek2 compact system AST 
card (bioMérieux-France) according to manufacturer instructions. It 
is an automated colorimetric method used for identification of 
bacteria and for detection susceptibility of bacterial isolates against 
different type of antibiotics. A suspension of overnight pure culture 
of S. pyogenes was prepared by transferring sufficient quantity of 
bacterial colonies to 3 ml of sterile saline (0.45%NaCl). The turbidity 
was adjusted to (0.5-0.63) MacFarland turbidity range and 
measured using a turbidity meter. Then, the suspension was 
transferred to the apparatus which contain the card that loaded with 
9 type of antibiotics included erythromycin, as indicated in Table 1. 
Measurement of MIC and sensitivity were done using optical 
system inside the apparatus and the result that was obtained after 
18 h of incubation were computerized analyzed which referred to 
the MIC and whether this isolate had sensitivity, intermediate 
sensitivity or resistant to each antibiotic found in the card. 
 
 
Identification of S. pyogenes strains using PCR 
 
Genomic DNA was extracted from S. pyogenes strains using 
WIZARD Genomic DNA Extraction Kit (Promega, USA) following 
manufacture instructions. For direct molecular identification of S. 
pyogenes, 16S rRNA and 16S-23S rRNA were used. Two primer 
sets were used for molecular identification of S. pyogenes (Table 2) 
(Nandi et al., 2008). Briefly, two PCR master mixes (final volume 25 
µl per reaction) were prepared, one for each gene as in the 
following: (final concentration per one réaction): 1XPCR buffer 
(Promega, USA), 200 µm dNTPs (Promega, USA), 100 pmol of 
each forward and reverse primers (Alpha, USA) and 1.25 U/reaction 
of GoTaq DNA polymerase (Promega, USA). Two microliters 
(equivalent to 100 ng) of DNA was added for each reaction tube, 
except the no template control tube (NTC). PCR
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Ampicillin 0.5,1,4,8 0.25            16 
Benzylpenicillin 0.06,0.12,0.5,2 0.06              8 
Cefotaxime 0.25,0.5,1,2 0.12              8 
Ceftriaxone 0.12,0.25,1,4 0.12              8 
Clindamycin 0.12,0.25,0.5 0.25              1 
Erythromycin 1,2,4,16 0.12              8 
Levofloxacin 1,2,4,16 0.25              16 
Tetracycline 0.12,0.25,1,4 0.25              16 




Table 2. Primer sequences and molecular size used in molecular identification of S. pyogenes. 
 
Gene Sequence of forward primer Sequence of reverse primer Product size (bp) 
16S rRNA (A) 5'AAGAGTTTGATCCTGGCTCAG3' 5'GGTTACCTTGTTACGACTT3' 1500 




Table 3. Primer sequences and molecular size used in erythromycin resistance genes. 
  
Gene Sequence of forward primer (5΄- 3΄) Sequence of reverse primer (5΄- 3΄) Product size (bp) 
erm (A) AGAAGGTTATAATGAAACAGA GGCATGACATAAACCTTCAT 260 
erm(B) GAAAAGGTACTCAACCAAATA AGTAACGGTACTTAAATTGTTTAC 640 




reaction tubes were transferred into thermal cycler (eppendrof, 
Germany) that was programmed as following: 94°C for 2 min 
followed by 35 cycles of 94°C for 1 min, 49°C for Gene A and  55°C 
for Gene B for 2 min, 72°C for 2 min. Final extension was done at 
72°C for 10 min. The selection of optimum annealing temperature 
came after multiple optimization experiments. PCR products (10 µl 
from each) were resolved by 1% agarose gel electrophoresis.  
 
 
Molecular  screening  for  erythromycin–résistant  gènes in  S. 
pyogenes 
 
The sequence of oligonucleotide primers sets used in PCR 
reactions to amplify resistance genes erm(A ), erm(B) and mef(A) 
are shown in Table 3. PCR reaction was done according to 
Morosini et al. (2003). Optimization for annealing temperature was 





Data were analyzed using SPSS version 16 and Microsoft Office 
Excel 2007. Nominal data were expressed as number and percent. 
Fischer Exact test was used for comparison of frequency. P-value 





Isolation and identification of S. pyogenes 
 
This  study  was  carried  out in 125 throat swabs isolated 
from throat of children from 2 to 12 years old. Fifty three 
of total samples were excluded from this study because 
no bacteria were isolated. The remaining 72 samples 
were identified using bacteriological test. Also, commercial 
Vitek2GP identification card was used and the identi-
fications probabilities were ranged from 86 to 99%. The 
results obtained by using Vitek2 GP identification system 
showed that 21 (29.2%) samples were S. pyogenes 
positive and 51(70.8%) samples were due to other 
causes of tonsillo-pharyngitis as shown in Table 4. The 
results of molecular identification of S. pyogenes strains 
using 16SrRNA and 16S-23SrRNA showed that only four 
strains were positive for 16S -23SrRNA, while two strains 




Distribution of streptococci throat infection in 
disease phases acute and chronic tonsillopharyngitis  
 
In this study, the number of isolates from acute cases 
were 5 isolates which represent (23.81%) of total cases 
while from chronic cases were 16 isolates which 
represent (76.19%) of total cases. 
 
 
Antimicrobial susceptibility patterns of S. pyogenes  
 
The antimicrobial susceptibility patterns of S. pyogenes




Table 4. Type and number of bacterial strains isolated from children with 
tonsillopharyngitis by using Vitek identification kit. 
 
Throat swab bacteria isolated  Number of strains Percentage (%) 
Streptococcus pyogenes 21 29.2 
Streptococcus agalactiae  2 2.8 
Streptococcus pneumonia  4 5.6 
Streptococcus mitis  2 2.8 
Streptococcus parasanguinis 2 2.8 
Staphylococcus aureus  41 56.8 






Figure 1. Agarose gel electrophoresis of amplified products of identification genes of S. pyogenes. (A) 
Agarose gel electrophoresis of amplified products of 16-23SrRNA of S. pyogenes. Lane MW, molecular 
weight ladder of 100 bp. lane 1, 2, 3 to 9: negative results of 16-23S rRNA (800 bp); lane 10, 11 and 11᷅ 
(as double): amplified products of 16-23S rRNA (800 bp); lane NTC, no template control. (B) Agarose gel 
electrophoresis of amplified products of 16S rRNA of S. pyogenes; lane MW, molecular weight ladder of 
100 bp; lane 1, 3, 4: amplified products of 16SrDNA (1500 bp); lane 2, 5 to 10, negative results of 
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Table 5.  The percentage of sensitivity patterns of S. pyogenes isolates against 
different types of antibiotics. 
 
Antibiotic  
Sensitive Resistant Intermediate 
Number % Number % Number % 
Benzyl Penicillin 21 100 0 0 0 0 
Ampicillin 21 100 0 0 0 0 
Cefotaxime 8 38.09 13 61.90 0 0 
Ceftriaxone 8 38.09 13 61.90 0 0 
Levofloxacine 20 95.23 0 0 1 4.76 
Erythromycin 11 52.38 7 33.33 3 14.28 
Clindamycin 15 71.43 6 28.57 0 0 
Tetracycline 10 47.62 11 52.38 0 0 




strains against various types of antibiotics according to 
Vitek 2 system were shown in Table 5.  
 
 
Molecular screening for erythromycin resistant genes 
in S. pyogenes  
 
According to the results of antibiotic sensitivity obtained 
by using Vitek2 AST system, there were seven strains 
resistant to erythromycin. The results of molecular 
screening for erythromycin resistant genes showed that 
none of these resistant strains have the resistant genes 
erm(A), erm(B) or mef (A).  
 
 
Telithromycin activity against erythromycin resistant 
strains of S. pyogenes 
 
The result of sensitivity test of telithromycin disc against 
erythromycin- resistant strains of S. pyogenes showed 
that 6 out of 7 strains have full sensitivity to Telithromycin 
disc with MIC value of ≤0.5 µg/ml while the remaining 
resistant strain showed intermediate sensitivity against 





Identification of S. pyogenes 
 
The important cause of the tonsillitis is bacterial and viral 
causes and about 30 to 40% of bacterial tonsillitis cases 
are caused by S. pyogenes (Abd Al-Kareem et al., 2004). 
Result of this study showed that from 72 patients with 
tonsillo-pharyngitis, 21 strains indicated the presence of 
S. pyogenes, 2 strains of Streptococcus agalactiae, 4 
strain of Streptococcus pneumonia, 2 strains of 
Streptococcus mitis, 2 strains of Streptococcus 
parasanguinis and 41 strain of Staphylococcus aureus. 
Kurien et al. (2000) and Wessels (2011) showed that the 
most common bacterial pathogens in the upper 
respiratory tract infection were S. pyogenes and S. 
aureus. In addition to identification by using Vitek2, S. 
pyogenes was identified using 16S rRNA and 16S-23S 
rRNA. The result showed that 4 strain out of 21 carried 
16S-23S rRNA, 2 out of these 4 strains additionally 
carried 16S rRNA. The absence of identification genes in 
the remaining S. pyogenes strains may be due to the 
genetic variations. It was refereed to that the absence of 
intra-species genetic variation at 16S rRNA subunit but 
documented variation in inter-genic 16S-23S spacer 
region (Clarridge, 2004; Petti et al., 2005; Nandi et al., 
2008; Lal et al., 2011). 
In this study, the percentage of S. pyogenes that 
caused chronic tonsillopharyngitis was 76.19%; this result 
was significantly higher than the results of Afaf et al. 
(2004) in Egypt who found that (18.5%) of the S. 
pyogenes strains were responsible for chronic 
tonsillopharyngitis. The low incidence of streptococcal 
tonsillopharyngitis in present study may be due to the 
relatively small number of the throat samples collected 
from patient with tonsillo-pharyngitis. 
 
 
Antibiotic susceptibility patterns of the S. pyogenes 
using Vitek2 AST system 
 
In this study, the susceptibility test of S. pyogenes strains 
using Vitek2 AST showed that all S. pyogenes strains 
were susceptible to penicillin group and penicillin remain 
the drug of choice for treatment of streptococcal 
pharyngitis, because the circumstances favorable for the 
development of resistance have not yet occurred, 
because this antibiotic is out of use in clinical practice in 
Iraq nowadays and the preference of the newest 
antibacterial drugs for prescription, as well as inefficient 
mechanisms for genetic transfer or barriers to DNA 
uptake and replication and β-Lactamase may not be 
expressed or may be potentially toxic to S. pyogenes 





Rubio-Lopez et al., 2012). Also, it could be that PBPs of 
S. pyogenes contain no lengthy regions of similarity with 
genes from other streptococci, making it unlikely that the 
acquisition of penicillin resistance arises by homologous 
recombination with genes from other species (Ferretti et 
al., 2001). This study shows that the susceptibility of 
strains to cefotaxime and ceftriaxone was 38.09% which 
is due to the extensive and random prescribing of these 
antibiotics before doing culture and sensitivity test, as 
well as those antibiotics in Iraq are supplied as over 
counter medicines in private pharmacies against the 
regulations. The results obtained by Young et al. (2004) 
in South Korea, Oliver et al. (2007) in Spain and Huang 
et al. (2014) in Taiwan, shows that the susceptibility of S. 
pyogenes to cefotaxime and ceftriaxone was 100%.  
In patients who are allergic to penicillin, macrolides 
such erythromycin and lincosamides such as clindamycin 
are alternative treatment choices (Shulman et al., 2012). 
In this study, the percentages of resistance of clindamycin 
and erythromycin for S. pyogenes were 28.75 and 
33.33%, respectively. Huang et al. (2014) showed that 
the resistance to clindamycin and erythromycin were 2.1 
and 16.4%, respectively. Other studies referred to low 
percentages of erythromycin resistance such as in 
America (8.6%), Asia-pacific region (10.9%), Europe 
(9.7%) and Latin America (2.7%) (Gordon et al., 2002). 
Shibl (2005) in Saudia Arabia showed that the resistant 
was only 6.3%, and similar percentages (4 to 10%) have 
been reported in Germany, UK, Portugal, Greece and 
Canada. The level of erythromycin resistance among 
strains was low which may be related to the low 
consumption of macrolides in these regions, or may be 
due to the absence of clonal spread of erythromycin-
resistant strains (Silva-Costa et al., 2012). The high 
percentage that is found in the current study could be 
attributed to high misuse of antibiotic in Iraq. 
 
 
Screening for erythromycin resistant gene 
 
Increases in macrolide resistance have been reported 
and the rapidly growing problem of antibiotic resistant S. 
pyogenes is increasing (Ray et al., 2010). In Iraq, 
information regarding the screening for erythromycin 
resistant genes of S. pyogenes strains was largely 
loosing. In this study, there were no strains related to S. 
pyogenes carrying the resistant genes. Bingen et al. 
(2000) referred that the predominance of a particular 
resistance genotype among macrolide-resistant strains 
were mefA in Spain (97% of 437 strains), Belgium (84% 
of 131 strains), Germany (56% of 54 strains) and Canada 
(92% of 72 strains) and ermB in France (55% of 93 
strains). Richter et al. (2005) refereed to that of the 
population of macrolide-resistant S. pyogenes strains in 
the United States comprises similar proportions of strains 
containing mefA (43%) and ermA (46%), with a smaller 
fraction of strains having ermB (8.5%) and considerable 
variation among regions. A study by Dundar et  al. (2010)   




in Turkey show that of 3 of 11 erythromycin resistant 
strains of S. pyogenes did not have erm(A), erm(B), and 
mef(A)  and this may be due to the ribosomal mutations. 
 
 
Effect of telithromycin on erythromycin resistant S. 
pyogenes 
 
In this study, 6 out of the 7 erythromycin resistant strains 
had high sensitivity to telithromycin with MIC value ≤ 0.5 
µg/ml while the remaining strain show intermediate 
resistance with MIC value range between 1 to 2 µg/ml. 
Such results may justify the effectiveness of this antibiotic 
as alternative of erythromycin in the treatment of 
streptococcal pharyngitis (Camara et al., 2013). 
Telithromycin was more active than 14 and 15 membered 
ring macrolides (azithromycin and clarithromycin) against 
erythromycin resistant S. pyogenes strains (Jalava et al., 
2001). Telithromycin show good activity against clinical S. 
pyogenes isolates including erythromycin A-resistant 
strains harboring the erm(A) or mef(A) (efflux) genotype.  
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